{{Rsnum
|rsid=4909764
|Gene=FAM135B
|Chromosome=8
|position=138243675
|Orientation=plus
|GMAF=0.07025
|Gene_s=FAM135B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 2.7 | 97.3
| HCB | 0.7 | 18.2 | 81.0
| JPT | 0.0 | 9.8 | 90.2
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 15.8 | 84.2
| CHB | 0.7 | 18.2 | 81.0
| CHD | 0.0 | 14.7 | 85.3
| GIH | 1.0 | 13.9 | 85.1
| LWK | 0.0 | 16.4 | 83.6
| MEX | 5.2 | 31.0 | 63.8
| MKK | 0.6 | 23.1 | 76.3
| TSI | 0.0 | 11.8 | 88.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=0.000002
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}